Please use this identifier to cite or link to this item:
Title: Sphingosine 1-phosphate receptor 2 induces otoprotective responses to cisplatin treatment
Authors: Wang, W. 
Shanmugam, M.K. 
Xiang, P. 
Yam, T.Y.A. 
Kumar, V. 
Chew, W.S. 
Chang, J.K.
Ali, M.Z.B. 
Reolo, M.J.Y. 
Peh, Y.X. 
Karim, S.N.B.A. 
Tan, A.Y.Y. 
Sanda, T. 
Sethi, G. 
Herr, D.R. 
Keywords: Acoustic startle response
Auditory brainstem response
Hearing loss
Reactive oxygen species
Sphingosine 1-phosphate
Issue Date: 2020
Publisher: MDPI AG
Citation: Wang, W., Shanmugam, M.K., Xiang, P., Yam, T.Y.A., Kumar, V., Chew, W.S., Chang, J.K., Ali, M.Z.B., Reolo, M.J.Y., Peh, Y.X., Karim, S.N.B.A., Tan, A.Y.Y., Sanda, T., Sethi, G., Herr, D.R. (2020). Sphingosine 1-phosphate receptor 2 induces otoprotective responses to cisplatin treatment. Cancers 12 (1) : 211. ScholarBank@NUS Repository.
Rights: Attribution 4.0 International
Abstract: Ototoxicity is a major adverse effect of platinum-based chemotherapeutics and currently, there remains a lack of United States Food and Drug Administration-approved therapies to prevent or treat this problem. In our study, we examined the role of the sphingosine 1-phosphate receptor 2 (S1P2) in attenuating cisplatin-induced ototoxicity in several different animal models and cell lines. We found that ototoxicity in S1P2 knockout mice is dependent on reactive oxygen species (ROS) production and that S1P2 receptor activation with a specific agonist, CYM-5478, significantly attenuates cisplatin-induced defects, including hair cell degeneration in zebrafish and prolonged auditory brainstem response latency in rats. We also evaluated the cytoprotective effect of CYM-5478 across different cell lines and showed that CYM-5478 protects neural-derived cell lines but not breast cancer cells against cisplatin toxicity. We show that this selective protection of CYM-5478 is due to its differential effects on key regulators of apoptosis between neural cells and breast cancer cells. Overall, our study suggests that targeting the S1P2 receptor represents a promising therapeutic approach for the treatment of cisplatin-induced ototoxicity in cancer patients. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.
Source Title: Cancers
ISSN: 2072-6694
DOI: 10.3390/cancers12010211
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3390_cancers12010211.pdf2.33 MBAdobe PDF




checked on May 13, 2022

Page view(s)

checked on May 12, 2022

Google ScholarTM



This item is licensed under a Creative Commons License Creative Commons